Jpmorgan Chase & CO Armata Pharmaceuticals, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 25 shares of ARMP stock, worth $49. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 26
3.85%
Holding current value
$49
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.39MCall Options Held
400Put Options Held
17.3K-
Bank Of America Corp Charlotte, NC634KShares$1.26 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA234KShares$463,5550.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$211,4420.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$198,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX75.4KShares$149,2560.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $71.6M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...